Insulin Glargine vs Ziconotide

Head-to-head comparison of Insulin Glargine (Insulin glargine (A21Gly,B31Arg,B32Arg human insulin analog)) and Ziconotide (ω-Conotoxin MVIIA (ziconotide)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyInsulin GlargineZiconotide
CategoryDiabetes & MetabolicPain Management
Full NameInsulin glargine (A21Gly,B31Arg,B32Arg human insulin analog)ω-Conotoxin MVIIA (ziconotide)
Molecular Weight6063.6 Da2639.1 Da
Half-LifeAbout 12-24 hoursapproximately 4.5 hours
Amino Acids5125
Typical Dose0.1-0.2 U/kg once daily0.5-19.2 mcg/day
RouteSubcutaneousIntrathecal
Purity≥98%≥98%
Studies Count13000500
Research StatusApprovedApproved

Insulin Glargine Benefits

  • Once-daily basal coverage
  • Smooth action profile
  • Lower nocturnal hypoglycemia risk
  • Improves fasting glucose control

Ziconotide Benefits

  • strong non-opioid analgesia
  • effective for refractory neuropathic pain
  • opioid-sparing option
  • intrathecal delivery allows targeted action

Insulin Glargine Dosing

Inject SC once daily at the same time each day|Titrate every 3-4 days to fasting glucose targets|Can be combined with prandial insulin

Ziconotide Dosing

start 0.5 mcg/day intrathecal|titrate by 0.5 mcg/day no more than 2 times weekly|max 19.2 mcg/day in labeling

Insulin Glargine Side Effects

  • Hypoglycemia
  • Injection-site reactions
  • Weight gain

Ziconotide Side Effects

  • dizziness
  • confusion
  • ataxia

Research Overview

Insulin Glargine

Clinical and translational studies support its use as a basal comparator because of prolonged absorption and stable glycemic control. It is heavily used in basal-bolus regimen research and insulin-delivery optimization studies.

Ziconotide

Clinical studies and post-marketing data support ziconotide as an analgesic for severe chronic pain that does not respond to conventional therapy. Research focuses on balancing analgesic efficacy with neuropsychiatric tolerability and careful dose titration.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Insulin Glargine stacks with:

Insulin LisproInsulin Aspart

Ziconotide stacks with:

BaclofenClonidineBupivacaine
basal insulinlong-actingfasting glucoseN-type calcium channel blockerneuropathic painnon-opioidintrathecal